Scout | BPN-Biologics: Funding for Biologic Neurotherapeutics from Lead Optimization to Phase 1

This opportunity is no longer accepting applications.

grant

BPN-Biologics: Funding for Biologic Neurotherapeutics from Lead Optimization to Phase 1

This FOA funds development of biologic-based therapies for nervous system disorders, supporting projects from lead optimization through optional Phase 1 clinical testing. Eligible approaches include proteins, antibodies, peptides, gene- and cell-based therapies, and emerging microbial/microbiome treatments; awardees can work with NIH consultants and use NIH CRO resources for manufacturing, PK/…

Source

Agency: National Institutes of Health

Program: FOA

Dates

Submission Deadline: August 19, 2024

Opportunity Released: March 11, 2021

Open for Submission: March 11, 2021

Application Window Closes: August 19, 2024

Keywords

neurotherapeutics

biologics

drug development

lead optimization

gene therapy

cell therapy

phase 1

ip retention

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers